MDP supplementation reduced adipose inflammation and glucose intolerance in obese mice via nucleotide-binding oligomerization domain (NOD2) and interferon regulatory factor 4 (IRF4) independently of weight loss or changes in microbiome composition [52]. Here, IRF4 is linked to Glucose intolerance.